IP Library › Granted Patent US 11,732,229
Granted Patent B2
US 11,732,229 · App. 17/100,542 · Granted Aug 22, 2023

Modular organ microphysiological system with integrated pumping, leveling, and sensing

Inventors: Linda Griffith (Cambridge, MA); David Trumper (Cambridge, MA); Collin Edington (San Mateo, CA); Gaurav Rohatgi (Boston, MA); Duncan Freake (Boston, MA); Luis Soenksen (Boston, MA); Brij Mohan Bhushan (Cambridge, MA)
Assignee: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
C12M23/12B01L3/50273B01L3/502715B01L3/502738C12M25/14C12M29/10F04B19/006F04B23/04F04B23/06F04B43/043F04B43/12B01L2200/0621B01L2300/0829B01L2300/0887B01L2400/0406B01L2400/0457B01L2400/0487B01L2400/0655B01L2400/086
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,732,229
App. No.
17/100,542
Granted
Aug 22, 2023
Kind
B2
Abstract

Fluidic multiwell bioreactors are provided as a microphysiological platform for in vitro investigation of multi-organ crosstalks for an extended period of time of at least weeks and months. The disclosed platform is featured with one or more improvements over existing bioreactors, including on-board pumping for pneumatically driven fluid flow, a redesigned spillway for self-leveling from source to sink, a non-contact built-in fluid level sensing device, precise control on fluid flow profile and partitioning, and facile reconfigurations such as daisy chaining and multilayer stacking. The platform supports the culture of multiple organs in a microphysiological, interacted systems, suitable for a wide range of biomedical applications including systemic toxicity studies and physiology-based pharmacokinetic and pharmacodynamic predictions. A process to fabricate the disclosed bioreactors is also provided.

Claims (36)

1. A fluidic multi-well device comprising:

a first plate comprising:

two or more wells comprising a three-dimensional space in each well defined by a bottom surface and a circumferential wall; and

an inlet and an outlet in each well;

a network of fluid paths providing fluid connectivity between at least two of the wells through the inlet and the outlet of each of the two wells;

wherein

the first and second wells are cell culture wells,

wherein a first well comprises a first transwell insert having a porous basal surface for attachment of cells in the first transwell, and a second well comprising a second transwell insert having a porous basal surface for attachment of cells in the second transwell, and

the first well has fluid paths for circulation of culture media in the first well to the basal side of the first transwell and the second well has fluid paths for circulation of culture media through the porous basal surface of the second transwell and into the first well.

2. The fluidic multi-well device of claim 1 further comprising a pneumatic manifold comprising

a detachable second plate comprising:

a plurality of internal channels, each with an inlet opening and an outlet opening on opposing sides of the second plate,

one or more holes on the surface of the second plate in connection with each of the internal channels; and

a barrier membrane positioned between the fluid paths of the first plate and the one or more holes on the surface of the second plate, wherein the barrier membrane is optionally bonded to the first plate,

wherein the barrier membrane is at least partially flexible, such that applying a pressure to the internal channels of the second plate causes the membrane to move, thereby obstructing or clearing a portion of the fluid paths of the first plate.

3. The fluidic multi-well device of claim 2 wherein the membrane is connected to the pneumatic manifold.

4. The fluidic multi-well device of claim 1 comprising an internal humidity sensor and/or a fluid moat to maintain humidity.

5. The fluidic multi-well device of claim 1 comprising fluidic pumping channels and a central modular pump and manifold to control fluid flow between the first well and the second well.

6. The fluidic multi-well device of claim 5 comprising a pump for flow fluid within the first well.

7. The fluidic multi-well device of claim 5 comprising a pump for fluid flow within the second well.

8. The fluidic multi-well device of claim 5 comprising pumping means with a flow rate between zero and hundreds of milliliters per day, optionally with a controlled volume flux between 0.1 and 10 microliter/stroke, and frequencies between about 0.1 Hz and 20 Hz.

9. The fluidic multi-well device of claim 5 comprising an oxygen or fluid level sensor or optical means for determining fluid levels.

10. The fluidic multi-well device of claim 5 further comprising a fluid aggregation lid.

11. The fluidic multi-well device of claim 5 comprising a symmetrical front and back electrode capacitor for use as a monitor.

12. The fluidic multi-well device of claim 1 comprising a perfusion-enabled removable scaffold.

13. A system comprising the fluidic multi-well device of claim 1 .

14. The system of claim 13 further comprising organ or tissue specific cells in the multi-well device.

15. The system of claim 14 comprising a multi-well device with cells of different origin in the same device.

16. The system of claim 15 wherein the cells are selected from the group consisting of liver cells, intestinal cells, pancreatic cells, muscle cells, bladder cells, kidney cells, pluripotent cells, and hematopoietic cells.

17. A method of culturing cells comprising seeding the device of claim 1 with cells.

18. The method of culturing cells of claim 17 further comprising exposing the cells to an agent to determine its effect on the cells.

19. The method of culturing cells of claim 18 further comprising administering the agent in different dosages, in a different dosing regimen, or in combination with one or more other agents and determining its effect on the cells.

20. The method of culturing cells of claim 18 wherein the agent is administered to different cell types or cell types associated with one or more diseases or disorders.

21. The fluidic multi-well device of claim 1 , wherein the first and second wells are connected to a mixer well with the network of fluid paths.

22. The fluidic multi-well device of claim 1 , wherein the first and second wells are interconnected by the network of fluid paths in an order replicating a physiological circulatory system for multi-organ culture.

23. The fluidic multi-well device of claim 1 , wherein of the first and second wells are each for culturing cells of different origin and comprise removable scaffolds.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 3, 2022
From: BHUSHAN, BRIJ MOHAN
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 061289/0430 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 7, 2021
From: GRIFFITH, LINDA; TRUMPER, DAVID; EDINGTON, COLLIN; SOENKSEN, LUIS; BHUSHAN, MOHAN BRIJ
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 054842/0206 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 7, 2021
From: ROHATGI, GAURAV; FREAKE, DUNCAN
To: CONTINUUM, LLC
Reel/Frame 054842/0278 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 7, 2021
From: CONTINUUM, LLC
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 054842/0371 →
Continuity (4)
Division 15425858 · Feb 6, 2017
Provisional Application 62359567 · Jul 7, 2016
Provisional Application 62291102 · Feb 4, 2016
Related Publication 20210139829A1 · May 13, 2021